Education
About Us
Working with TipRanks
Follow Us
Quoin Pharmaceuticals (QNRX)
NASDAQ:QNRX
Total Valuation
Quoin Pharmaceuticals has a market cap or net worth of $4.59M. The enterprise value is $977.31K.
Market Cap$4.59M
Enterprise Value$977.31K
Share Statistics
Quoin Pharmaceuticals has 588,167 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding588,167
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Quoin Pharmaceuticals’s return on equity (ROE) is -0.97 and return on invested capital (ROIC) is -0.08%.
Return on Equity (ROE)-0.97
Return on Assets (ROA)-570.52
Return on Invested Capital (ROIC)-0.08%
Return on Capital Employed (ROCE)-0.83
Revenue Per Employee0.00
Profits Per Employee-2.99B
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio0.81
Price to Fair Value<0.01
Price to FCF-0.53
Price to Operating Cash Flow-0.53
PEG Ratio0.03
Income Statement
In the last 12 months, Quoin Pharmaceuticals had revenue of 0.00 and earned -8.96B in profits. Earnings per share was -1.91K.
Revenue0.00
Gross Profit0.00
Operating Income-9.57M
Pretax Income-8.96B
Net Income-8.96B
EBITDA-8.90M
Earnings Per Share (EPS)-1.91K
Cash Flow
In the last 12 months, operating cash flow was -322.83K and capital expenditures 0.00, giving a free cash flow of -322.83K billion.
Operating Cash Flow-322.83K
Free Cash Flow-322.83K
Free Cash Flow per Share-0.55
Dividends & Yields
Quoin Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.24
52-Week Price Change-67.52%
50-Day Moving Average8.70
200-Day Moving Average13.91
Relative Strength Index (RSI)24.66
Average Volume (3m)5.40K
Important Dates
Quoin Pharmaceuticals upcoming earnings date is Aug 14, 2025, Before Open (Confirmed).
Last Earnings DateMay 13, 2025
Next Earnings DateAug 14, 2025
Ex-Dividend Date―
Financial Position
Quoin Pharmaceuticals as a current ratio of 3.57, with Debt / Equity ratio of 0.00%
Current Ratio3.57
Quick Ratio3.57
Debt to Market Cap0.00
Net Debt to EBITDA0.41
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Quoin Pharmaceuticals has paid -8.95B in taxes.
Income Tax-8.95B
Effective Tax Rate1.00
Enterprise Valuation
Quoin Pharmaceuticals EV to EBITDA ratio is 0.40, with an EV/FCF ratio of 0.45.
EV to Sales0.00
EV to EBITDA0.40
EV to Free Cash Flow0.45
EV to Operating Cash Flow0.45
Balance Sheet
Quoin Pharmaceuticals has $11.55M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$11.55M billion.
Cash & Marketable Securities$11.55M
Total Debt$0.00
Net Cash-$11.55M
Net Cash Per Share-$19.64
Tangible Book Value Per Share$65.10
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Quoin Pharmaceuticals is $70.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$70.00
Price Target Upside944.78% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast42.26%